BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34510454)

  • 21. Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.
    Cienfuegos JA; Rotellar F; Baixauli J; Beorlegui C; Sola JJ; Arbea L; Pastor C; Arredondo J; Hernández-Lizoáin JL
    Ann Surg Oncol; 2015 Mar; 22(3):916-23. PubMed ID: 25190129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
    Hongo K; Kazama S; Tsuno NH; Ishihara S; Sunami E; Kitayama J; Watanabe T
    World J Surg Oncol; 2015 Jan; 13():7. PubMed ID: 25622595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative chemoradiotherapy in rectal cancer induces changes in the expression of nuclear β-catenin: prognostic significance.
    Gomez-Millan J; Perez L; Aroca I; Del Mar Delgado M; De Luque V; Román A; Torres E; Ramos S; Perez S; Bayo E; Medina JA
    BMC Cancer; 2014 Mar; 14():192. PubMed ID: 24629143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
    Huang WS; Kuan FC; Lin MH; Chen MF; Chen WC
    Ann Surg Oncol; 2020 Oct; 27(11):4309-4318. PubMed ID: 32794029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 27. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of Early Distant Relapse in Rectal Cancer Patients Submitted to Preoperative Chemoradiotherapy.
    Restivo A; Delrio P; Deidda S; Spolverato G; Rega D; Cerci M; Barina A; Perin A; Pace U; Zorcolo L; Pucciarelli S
    Oncol Res Treat; 2020; 43(4):146-152. PubMed ID: 32036373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW; Jensen HA; Pfeiffer P
    Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of concurrent chemotherapy regimen on clinical outcomes of preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim E; Kim K; Oh H; Han SW; Kim TY; Jung SY; Park KJ; Kang GH; Chie EK
    J BUON; 2019; 24(2):470-478. PubMed ID: 31127993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Chemoradiation Followed by Extensive Pelvic Surgery Improved the Outcome of Posterior Invasive Locally Recurrent Rectal Cancer without Deteriorating Surgical Morbidities: A Retrospective, Single-Institution Analysis.
    Ogawa H; Uemura M; Nishimura J; Hata T; Ikenaga M; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Yamamoto H; Doki Y; Mori M
    Ann Surg Oncol; 2015 Dec; 22(13):4325-34. PubMed ID: 25893408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer.
    Sakr A; Elsherbiny M; Abdel Moneim R; Shaaban S; Aldaly M
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1717-1723. PubMed ID: 32592369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer.
    Sohn DK; Han KS; Kim BC; Hong CW; Chang HJ; Baek JY; Kim MJ; Park SC; Oh JH; Kim DY
    Surg Oncol; 2017 Dec; 26(4):453-459. PubMed ID: 29113665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable?
    Huh JW; Kim CH; Kim HR; Kim YJ
    Surgery; 2011 Nov; 150(5):980-4. PubMed ID: 21875732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer.
    Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer.
    Song M; Geng J; Wang L; Li Y; Zhu X; Li X; Mi L; Wu A; Peng Y; Yao Y; Zhang Y; Wang H; Shi C; Cai Y; Wang W
    Radiat Oncol; 2019 Aug; 14(1):138. PubMed ID: 31382984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.
    Yeo SG; Kim DY; Park JW; Oh JH; Kim SY; Chang HJ; Kim TH; Kim BC; Sohn DK; Kim MJ
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e193-9. PubMed ID: 21605941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy.
    Park SE; Hwang IG; Choi CH; Kang H; Kim BG; Park BK; Cha SJ; Jang JS; Choi JH
    Medicine (Baltimore); 2018 Nov; 97(48):e13363. PubMed ID: 30508928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Tomono A; Yamashita K; Kanemitsu K; Sumi Y; Yamamoto M; Kanaji S; Imanishi T; Nakamura T; Suzuki S; Tanaka K; Kakeji Y
    Int J Clin Oncol; 2016 Apr; 21(2):344-349. PubMed ID: 26338272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
    Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.